{"name":"Enteris BioPharma Inc.","slug":"enteris-biopharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Leuprolide Depot","genericName":"Leuprolide Depot","slug":"leuprolide-depot","indication":"Advanced prostate cancer","status":"marketed"}]}],"pipeline":[{"name":"Leuprolide Depot","genericName":"Leuprolide Depot","slug":"leuprolide-depot","phase":"marketed","mechanism":"Leuprolide is a gonadotropin-releasing hormone (GnRH) agonist that suppresses luteinizing hormone and follicle-stimulating hormone, leading to decreased testosterone and estrogen production.","indications":["Advanced prostate cancer","Endometriosis","Uterine fibroids (leiomyomata)","Precocious puberty","Breast cancer (premenopausal women)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOYWhyTHRmd054WjUtX2NMVEVIbXExajFSSE9ZWU1vWW56N2VLSnZIczNNd2ZjWFAxcWV1SzQtRk9LY3RoWFBhZFpuWkNnTHFuX2oxSE52Rjh0dEVGSVFRSWpVU1c0RTZNTklQVEhlRmlzRDVHY05uaXBQSmpNa2pja2hNQmJBRTg5Y3k1a1VXZGlfdWoxcUN6eDhfMWFOSkUwT2lKSEdVNnVGSHpZS19sMmln?oc=5","date":"2025-07-15","type":"trial","source":"Aptar","summary":"Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition - Aptar","headline":"Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQU05ucEE5Y2t0eWtrLXFMdkV6eEplNDR2dTRGQ2ZSMGVYTURpVHdFZmNTTFZtVWEzVDlNNnZyZ09fSktCaXFYLV9jNGtoNkV2TkRRRHJLcXpLTXhOSFRnY2NxQ2JjS2VHSVdENVpCQ1hjN1NFQjBoQmhfRVNBa3FBYVRYa0cwOERmYkFYSmozQTNFWG8zUHk3LV9WT3pPY2F5a2lPeURDX2F2YzNaMTRjejJ4Vld2cTdUTTB4MlFR?oc=5","date":"2024-04-25","type":"regulatory","source":"Fierce Pharma","summary":"Utility Therapeutics wins FDA nod for UTI antibiotic that has been on the market in Europe for 40-plus years - Fierce Pharma","headline":"Utility Therapeutics wins FDA nod for UTI antibiotic that has been on the market in Europe for 40-plus years","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-06-22","type":"pipeline","source":"PR Newswire","summary":"Osteoporosis Market to Accelerate Substantially, Assesses DelveInsight | Key Companies to Look Out For - Teva, Novartis, Amgen, USB, Jiangsu HengRui Medicine, Shanghai JMT-Bio, Eli Lilly and Company, ","headline":"Osteoporosis Market to Accelerate Substantially, Assesses DelveInsight | Key Companies to Look Out For - Teva, Novartis,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPTkJNYkdhUWJtY1pYV2xfQUlScW5teFhhNVp1ek1TcWdEWi16LVNaSHhOYjUxZUQyMkRwYnFzZjE0SUFwU2ctdjVDc01ueDNaM0lNd2JCQUtpMTNMY1JyM1NnWE1RcFhtWE9vUURySnNNZHNRZ3AzVlFoWG4tUGJ3Vk1IQkd5b1l1RVRxY2E2XzNsUDFQNFBCM0NEdms5bEFtdEhSUDdsei1sazVTWHc?oc=5","date":"2021-06-11","type":"pipeline","source":"Contract Pharma","summary":"Enteris BioPharma Receives $10M Milestone from Cara Therapeutics - Contract Pharma","headline":"Enteris BioPharma Receives $10M Milestone from Cara Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOdENoSW1VYnBTOUh4djVwaWNWMGVrbUp5WkRkR2lUNWJ6WHF4dWY5ekZSZmNtd0RRTGp5dHI5bTBGbFU2elZwaXFQaXlFdENjYk1zTk9UZEhreTZXQWpKby1pbU8teG0tbWYzekhGUFRraGRLc2dCRlN1R1VMZ0FZekV6Q2I1a0VSVmRtOFdmQ2luX1Y2NXN4VXE0alpKTEUtelhLemlNU3Z5dEFfc1E?oc=5","date":"2021-05-11","type":"pipeline","source":"Contract Pharma","summary":"Enteris BioPharma Completes Expansion of Manufacturing Facility - Contract Pharma","headline":"Enteris BioPharma Completes Expansion of Manufacturing Facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNeUJnd3RsSElFZGQtblhOaHdaTGdVeUd6WUhJeG0xeF9rU1U4WTRNcUtkcEt1al85bkhDNWRFVHUzQ3oydTRtTWRXckwzelZORTJYbEhQWHZoUk5tMXZqb0hMam1nZUdhZzdJdWxLRnZKVExNX2ZQLWoxd2lJVXVOajNVWUJKcjIxc012MjJZVk1aNGpRMVNMMU9oQ2xiUDFZbjBDRWdCRQ?oc=5","date":"2018-01-04","type":"pipeline","source":"BioPharma Dive","summary":"Enteris’ endometriosis drug moves ahead with proof-of-concept - BioPharma Dive","headline":"Enteris’ endometriosis drug moves ahead with proof-of-concept","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOUGl6MU10WDFXWFJZbjRnNHFCdXdJN2Nuc0pCWUYtMzRGMzlIc19pakVZLVpyNkp5cVNfdjBHalpyUmRrYldJdURscFZaaDdwNWVfWC1HdXE2ZWhfWUVpdlBsb2c4blFuWlhCSmZaUVFuNG85YUdNMlBzWUoxTlN3TjdXNmFKYnh5U0FtbWxkZ3Y?oc=5","date":"2017-01-23","type":"pipeline","source":"Fierce Biotech","summary":"Enteris BioPharma signs oral diabetes pact with Sanofi - Fierce Biotech","headline":"Enteris BioPharma signs oral diabetes pact with Sanofi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNMFhVRHZ1dm9HRU9ieE9WVzgzR0lhd0JhM0FBVWFZQnhRaEszMWNobHllczItU21mRFdkaWh0UFNOYkxmYk9OdnpvUmRMOWh1dWRuSC03TDNJNFE2SGxaQTdqTkE5ZHVkSGl0XzB2NDR6cllDM1RTQWZYZklHNUItZWl1Nk5qMXEzdnZMLUpMN0hQdmFiVmxOMkN6N2VBbGFGcmNz?oc=5","date":"2016-07-19","type":"trial","source":"Fierce Pharma","summary":"Enteris BioPharma begins study of its oral drug to treat UTIs - Fierce Pharma","headline":"Enteris BioPharma begins study of its oral drug to treat UTIs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQcEhwNDY4NnQwNDdOU194b293NEJPMWEyaENwSFMxUDZTWDY0WG9RTExkX1M4ZEp6N0dVcGVrcWpzQi1Oa0xfR1pveXVNa2xNLVNrcElQOXdKX0loaHpqdHVjN1RKRHNrUjFHdUxjZ2VTalBkbXZCTk4zbkxIMExnMmJadDJ4emUyM3NqUDJ3ZVJwdlFZcDZELXZCeFdIY09tNEZQcEVidXBIUnM?oc=5","date":"2015-02-11","type":"pipeline","source":"Technology Networks","summary":"Enteris BioPharma Launches Contract Manufacturing - Technology Networks","headline":"Enteris BioPharma Launches Contract Manufacturing","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}